Title: Efficacy of extracorporeal immunoadsorption therapy for removal of HBsAg
Version: 2 Date: 22 Mar 2025
Reviewer:  Yoshihiko Yano
Reviewer's report:
The revised manuscript was mostly well modified. Some points should be checked up.
1. Especially, there are many errors in the wording of the revised section and should be checked
up again; “ARCHITECT i2000SR mechine”, “TP”, “in vitro” et al.
2. Abbreviations for example, “cccDNA, pgRNA” that appear for the first time should be listed
without abbreviation.
3. Figure 4, (%) should be written exactly.
Title: Efficacy of extracorporeal immunoadsorption therapy for removal of HBsAg
Version: 2 Date: 22 Mar 2025
Reviewer:  Yoshihiko Yano
Reviewer's report:
The revised manuscript was mostly well modified. Some points should be checked up.
1. Especially, there are many errors in the wording of the revised section and should be checked
up again; “ARCHITECT i2000SR mechine”, “TP”, “in vitro” et al.
2. Abbreviations for example, “cccDNA, pgRNA” that appear for the first time should be listed
without abbreviation.
3. Figure 4, (%) should be written exactly.
Please review this paper.
user
Title: Efficacy of extracorporeal immunoadsorption therapy for removal of HBsAg
Version: 2 Date: 22 Mar 2025
Reviewer:  Yoshihiko Yano
Reviewer's report:
The revised manuscript was mostly well modified. Some points should be checked up.
1. Especially, there are many errors in the wording of the revised section and should be checked
up again; “ARCHITECT i2000SR mechine”, “TP”, “in vitro” et al.
2. Abbreviations for example, “cccDNA, pgRNA” that appear for the first time should be listed
without abbreviation.
3. Figure 4, (%) should be written exactly.
assistant